Skip to content
Screener

Price / book at other companies

Amgen logo
AmgenAMGN
16.7×-3.4×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
2.1×+0.2×
Gilead Sciences logo
Gilead SciencesGILD
13.3×+6.5×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
3.1×+0.7×
Biohaven logo
BiohavenBHVN
9.8×+0.4×
Assembly Biosciences logo
Assembly BiosciencesASMB
2.2×-0.4×

Other financials

Income statement

See full
Revenue$238.9M+19,583%
Gross profit$238.9M+19,763%
Operating income$73.5M+162%
Net income$80.1M+172%
EPS (diluted)$0.47+159%

Balance sheet

See full
Cash & equivalents$287.6M-6.1%
Total debt$93.3M-8.8%
Total equity$982.5M+3.7%
Total assets$1.2B+1.9%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$32.0K-98.7%
Free cash flow-$132.8M-66.5%

Valuation

See full
Market cap$1.48B+111%
Enterprise value$1.29B+159%
P/S4.9×-32.1×

Profitability

See full
Gross margin96.1%-2.7pp
Operating margin-92.4%-45.5pp
Net margin-83%-40.9pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-26.1%-7.9pp
Debt / equity0.1×0.0×
Current ratio-1.0×

Where this comes from

Calculated from Vir Biotechnology, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 5:20 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053549

FAQ

What is Vir Biotechnology, Inc.'s price / book?
Vir Biotechnology, Inc. (VIR) reported price / book of 1.7× in Q2 2026.
How has Vir Biotechnology, Inc.'s price / book changed year-over-year?
Vir Biotechnology, Inc.'s price / book increased by 127.5% year-over-year, from 0.8× to 1.7×.
What is the long-term trend for Vir Biotechnology, Inc.'s price / book?
Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s price / book has grown at a -25.8% compound annual growth rate (CAGR), from 4.9× to 1.1×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Vir Biotechnology, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude